COMMONWEALTH EQUITY SERVICES, LLC

Position in BCAB — BioAtla, Inc.

CIK 312272 WALTHAM, MA

Position in BCAB

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$4,073

-$10,297 QoQ

Shares Held

25,300

0.0% QoQ

Ownership

1.52%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

15 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,073	25,300	0.0%	Shares	Sole	2026-04-27
2025-12-31	$14,370	25,300	0.0%	Shares	Sole	2026-02-12
2025-09-30	$17,406	25,300	0.0%	Shares	Sole	2025-10-22
2025-06-30	$10,018	25,300	0.0%	Shares	Sole	2025-08-06
2025-03-31	$8,779	25,300	+16.1%	Shares	Sole	2025-05-09
2024-12-31	$12,883	21,800	0.0%	Shares	Sole	2025-02-10
2024-09-30	$38,368	21,800	0.0%	Shares	Sole	2024-10-18
2024-06-30	$29,866	21,800	-9.1%	Shares	Sole	2024-07-31
2024-03-31	$82,535	23,993	+10.1%	Shares	Sole	2024-04-29
2023-12-31	$53,628	21,800	0.0%	Shares	Sole	2024-02-06
2023-09-30	$37,060	21,800	0.0%	Shares	Sole	2023-10-23
2023-06-30	$65,400	21,800	0.0%	Shares	Sole	2023-08-10
2023-03-31	$58,424	21,800	+9.0%	Shares	Sole	2023-05-11
2022-12-31	$165,000	20,000	+42.9%	Shares	Sole	2023-02-07
2022-06-30	$39,900	14,000	—	Shares	Sole	2022-07-19
No filing history on record for this holder in this stock.